During CKD progression, diminished expression of FAO enzymes, together with perturbations in key nuclear receptors (PPAR-α, PPAR-γ, and FXR), alters FA uptake machinery and downstream lipid–metabolic pathways, thereby accelerating tubulointerstitial fibrosis [41]. The gene discussed is NR1H4; the disease is chronic kidney disease.